Use of Mode and Effects Analysis (FMEA) as a tool to map the risks involved in a clinical study
DOI:
https://doi.org/10.22239/2317-269X.01024Keywords:
Clinical Research, Risk Management, FMEAAbstract
Introduction: This study describes the application of the Failure Mode and Effects Analysis (FMEA) as a tool for risk management during clinical research to establish the treatment of patients simultaneously infected with HIV and tuberculosis. Objective: To demonstrate the importance of risk analysis associated with clinical trial protocols in safeguarding the participant and study data, and as a study’s quality standard. Method: Procedures demanded by the clinical protocol were detailed and then associated with failure modes based on the programmed visits of the participant to the study center. The failure modes were rated between 1 and 10 according to: Severity, Occurrence and Detectability, and the Risk Priority Number (RPN) was calculated by multiplying the three values. Results: In a panel of 25 procedures and 60 failure modes, 50% resulted in RPN > 120; six of which contained more than five failure modes. The highest risks were associated with the DOT strategy (RPN 294), blood collection (RPN 288), the Informed Consent Term (RPN 270) and participant data collection (RPN 240). Conclusions: The results demonstrate the importance of FMEA as a tool to assess risks in clinical studies, in line with the recommendations of international standardization organizations.Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Health Surveillance under Debate: Society, Science & Technology (Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnología) – “Visa em Debate”
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
COPYRIGHT ALLOWANCE The author (s) hereinafter designated as the ASSIGNOR hereby assign and transfer, free of charge, the ownership of the copyrights related to this ARTICLE to the Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debate, represented by FUNDAÇÃO OSWALDO CRUZ, established at Av. Brasil, nº 4365, Manguinhos, Rio de Janeiro, RJ, Brazil, CEP 21045-900, under the conditions set out below: (a) The terms and conditions set forth in this Agreement shall apply to the following: 1. The ASSIGNOR declares that they s(he) is (are) the author (s) and owner (s) of the copyrighted property of the ARTICLE submitted. 2. The ASSIGNOR declares that the ARTICLE does not infringe the copyrights and / or other property rights of third parties, that the disclosure of images (if any) has been authorized and that they s(he) assume(s) full moral and / or property liability for its content, before third parties. 3. THE ASSIGNOR assigns and transfers all copyrights relating to the ARTICLE to the ASSIGNEE, especially the rights of editing, publication, translation into another language and reproduction by any process or technique. The ASSIGNEE becomes the exclusive owner of the rights related to the ARTICLE, and any reproduction, totally or partially, is prohibited in any other means of publicity, printed or electronic, without prior written authorization from the ASSIGNEE. 4. The assignment is free and, therefore, there will be no remuneration for the use of the ARTICLE by the ASSIGNEE.
